Voyager Therapeutics (VYGR) Gains from Investment Securities (2014 - 2015)
Voyager Therapeutics (VYGR) posted Gains from Investment Securities of $9.8 million for Q1 2015, up 4900.0% sequentially from $195000.0 in Q4 2014.
Voyager Therapeutics (VYGR) Gains from Investment Securities (2014 - 2015) Analysis & Trends
Voyager Therapeutics has reported Gains from Investment Securities for 2 years, with the latest figure at $9.8 million in Q1 2015.
- Quarterly Gains from Investment Securities changed N/A year-over-year to $9.8 million in Q1 2015, while the trailing twelve-month figure through Dec 2015 was $9.8 million (changed N/A YoY) and the FY2016 annual result came in at $9.8 million, up 0.51% from the prior year.
- Gains from Investment Securities rose to $9.8 million in Q1 2015 per VYGR's latest filing, from $195000.0 in the prior quarter.
- Over five years, Gains from Investment Securities peaked at $9.8 million in Q1 2015 and troughed at $195000.0 in Q4 2014.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Voyager Therapeutics | 205.86 Mn | 89.52 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2015 | 9.75 Mn |
| Mar 31, 2015 | 9.75 Mn |
| Dec 31, 2014 | 195,000.00 |
| Dec 31, 2014 | 195,000.00 |